Studies show that TTI-621 could block the “do not eat me” signal of CD47 and boost phagocytosis and anti-tumor effect, and intra-tumoral injections of TTI-621 are used to treat patients with mycosis fungoides and/or Sézary syndrome, which result in a rapid decrease in tumor size [89,90,91]. This evidence concerns the gene CD47 and neoplasm.